| Detailed information |
|---|
| CancerLivER ID | 2372 |
| Biomarker | PDHA1/A2/B |
| Biomarker Name/Symbol (given in Publication) | PDHA1/A2/B |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potenial Diagnostic marker for HCC; but not validated on independent patient cohort |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC than non-tumor |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 11752456 |
| Type of Biomarker | Diagnostic |
| Pathway | Citrate cycle (TCA cycle) and Central carbon metabolism in cancer. |
| Cohort | Paired tumor and non-tumor tissue samples form 29 HBV-associated HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2001 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |